The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Edwards, 1991, Invasive Candida infections. Evolution of a fungal pathogen, N Engl J Med, 324, 1060, 10.1056/NEJM199104113241511
Beck-Sague, 1993, the National Nosocomial Infectious Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990, J Infect Dis, 167, 1247, 10.1093/infdis/167.5.1247
Wey, 1988, Hospital-acquired candidemia. The attributable mortality and excess length of stay, Arch Intern Med, 148, 2642, 10.1001/archinte.1988.00380120094019
Wey, 1989, Risk factors for hospital-acquired candidemia. A matched case-control study, Arch Intern Med, 149, 2349, 10.1001/archinte.1989.00390100145030
Dyess, 1985, Candida species. Implications of polymicrobial blood-borne infection, Arch Surg, 120, 345, 10.1001/archsurg.1985.01390270083014
Fraser, 1992, Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality, Clin Infect Dis, 15, 414, 10.1093/clind/15.3.414
Horn, 1985, Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy, Rev Infect Dis, 7, 646, 10.1093/clinids/7.5.646
Klein, 1979, Hospital-acquired fungemia. Its natural course and clinical significance, Am J Med, 67, 51, 10.1016/0002-9343(79)90073-1
Komshian, 1989, Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome, Rev Infect Dis, 3, 379, 10.1093/clinids/11.3.379
Meunier-Carpentier, 1981, Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality, Am J Med, 71, 363, 10.1016/0002-9343(81)90162-5
Nielsen, 1991, Fungemia in a university hospital 1984–1988, Scand J Infect Dis, 23, 275, 10.3109/00365549109024310
Young, 1974, Fungemia with compromised host resistance, Ann Intern Med, 80, 605, 10.7326/0003-4819-80-5-605
Wingard, 1991, Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole, New Engl J Med, 325, 1274, 10.1056/NEJM199110313251803
Persons, 1991, Fluconazole and Candida krusei fungemia (Letter), N Engl J Med, 325, 1315, 10.1056/NEJM199110313251814
Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301
Winston, 1993, Fluconazole prophylaxis of fungal infections in patients with acute leukemia, Ann Intern Med, 118, 495, 10.7326/0003-4819-118-7-199304010-00003
National Committee for Clinical Laboratory Standards, 1992, Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard, NCCLS document M27-P, 12, 1
Nguyen, 1995, Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective observational study, Arch Intern Med, 155, 2429, 10.1001/archinte.1995.00430220087009
Price, 1994, Fluconazole susceptibilities of Candida species and distribution of species recovered from blood culture over a 5-year period, Antimicrob Agents Chemother, 38, 1422, 10.1128/AAC.38.6.1422
Berkowitz, 1979, Torulopsis glabrata fun-gemia: a clinical pathological study, Medicine, 58, 430, 10.1097/00005792-197911000-00003
Pappagianis, 1979, Development of resis-tance to amphotericin B in Candida lusitaniae infecting a human, Antimicrob Agents Chemother, 16, 123, 10.1128/AAC.16.2.123
Merz, 1979, Isolation and characterization of a polyene-resistant variant of Candida tropicalis, J Clin Microbiol, 9, 677, 10.1128/jcm.9.6.677-680.1979
Guinet, 1983, Fatal septicemia due to amphotericin B-resistant Candida lusitaniae, J Clin Microbiol, 18, 433, 10.1128/JCM.18.2.443-444.1983
Nguyen, 1996, Candida lusitaniae: an important emerging cause of candidemia. Occurrence during a prospective fungemia study, Infect Dis Clin Prac, 10.1097/00019048-199605000-00010
Rex, 1994, A randomized trial comparing fluconazole with amphotericin B for the treatment in patients without neutropenia, N Engl J Med, 331, 1325, 10.1056/NEJM199411173312001
Pfaller, 1994, Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients in AIDS and oral candidiasis, J Clin Microbiol, 32, 59, 10.1128/JCM.32.1.59-64.1994
Cameron, 1993, Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type I, Antimicrob Agents Chemother, 37, 2449, 10.1128/AAC.37.11.2449
Sandven, 1993, Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance, Antimicrob Agents Chemother, 37, 2443, 10.1128/AAC.37.11.2443
Willocks, 1991, Fluconazole resistance in AIDS patients, J Antimicrob Chemother, 28, 937, 10.1093/jac/28.6.937
Sangeorzan, 1994, Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance, Am J Med, 97, 339, 10.1016/0002-9343(94)90300-X
Dick, 1980, Incidence of polyene-resistant yeasts recovered from clinical specimens, Antimicrob Agents Chemother, 18, 158, 10.1128/AAC.18.1.158
Dick, 1985, Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii, Ann Intern Med, 102, 67, 10.7326/0003-4819-102-1-67
Fan-Havard, 1991, Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy, Antimicrob Agents Chemother, 35, 2302, 10.1128/AAC.35.11.2302
Powderly, 1988, Amphotericin B-resistant yeast infection in severely immunocompromised patients, Am J Med, 84, 826, 10.1016/0002-9343(88)90059-9
Bodenhoff, 1968, Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged antimycotic treatment, Odontol Tidskr, 76, 279